BioNTech SEBNTXNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank13
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P13
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-105.24%
2023-64.69%
20221696.13%
2021843.88%
202063.32%
2019-113.91%
2018-14.26%
20170.00%
20160.00%